ArticleJTO clinical and research reports2024

Initial Safety and Feasibility Results From a Phase 1, Diagnose-and-Treat Trial of Neoadjuvant Intratumoral Cisplatin for Stage IV NSCLC.

Farrah B Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.